Skip to content

Individual Response to Different Volumes of Resistance Training

Determinants of Intra-individual Variation in Adaptability to Resistance Training of Different Volumes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02179307
Enrollment
42
Registered
2014-07-01
Start date
2014-08-31
Completion date
2015-04-30
Last updated
2015-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

muscle hypertrophy, strength, resistance training, exercise, physical fitness, health, physical conditioning

Brief summary

The literature is not clear as to which training volume to employ during initial phases of resistance training programs to ensure optimal muscular adaptations. The purpose of this study is therefore to compare effects of strength training with low versus moderate volume on muscular function and hypertrophy in previously untrained, healthy individuals. Furthermore, the investigators will relate individual variation in responses to proxy markers of individual training state, such as baseline muscular function and muscle fiber type. The study will include 25 women and 25 men and will consist of a 12-week resistance training protocol. Each study participant will act as their own control, performing both the low- (1-set) and the moderate-volume (3-sets) protocol, allocated to either the dominant or non-dominant leg, in a stratified and randomized fashion. Primary outcome measures are thigh muscle cross section area and unilateral knee extension strength. Additionally, muscle fiber type composition will be evaluated as well as additional parameters of muscular function. The primary hypothesis is that low-volume protocols will be beneficial for individuals with glycolytic muscle phenotypes, whereas the opposite will be true for individuals with more aerobic phenotypes.

Interventions

BEHAVIORAL12-week progressive strength training protocol

Every study participant will complete 12 weeks of progressive strength training with one leg performing 1-set per exercise per session and the contralateral leg performing 3-sets per exercise per session. Allocation of dominant/non-dominant leg to either 1- or 3-set protocol will be done in a stratified, randomized fashion (stratified with regard to sex and baseline strength).

Sponsors

Sykehuset Innlandet HF
CollaboratorOTHER
Revmatismesykehuset AS
CollaboratorOTHER
Inland Norway University of Applied Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * Non-smoking * Able to tolerate resistance exercise training

Exclusion criteria

* Presence or history of cardiovascular, metabolic, endocrine or neuromuscular disease * Diagnosed mental health disorder * Intolerance to local anesthetic * No experience with exercise training * Performing regular resistance training (more than 1 session per week during last 12 months) * Impaired strength/ neuromuscular function due to previous injury * Recurrent pain in lower back, knee or shoulders * Taking prescribed medication that may affect outcome of training intervention

Design outcomes

Primary

MeasureTime frameDescription
Unilateral knee-extension isometric strengthWeek 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)Time course changes in maximum knee extensor, isometric strength evaluated at 120° knee angle (180° fully extended).
Thigh muscle cross-sectional areaWeek 0 (baseline) and 12 (post training intervention)Changes in muscle cross sectional area of each thigh from baseline to post intervention, assessed by MRI.

Secondary

MeasureTime frameDescription
Knee extensors and flexors force-velocity relationshipWeek 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)Time course changes in torque measured during maximal voluntary isokinetic contraction at 60°, 120° and 240° ∙ sec-1.
Blood hormonal profilesWeek 0 (baseline), 2 and 12 (post training intervention)Resting (week 0, 2 and 12) and acutely exercise-induced (week 2) hormonal profiles (testosterone, insulin-like growth factor 1, growth hormone and cortisol) determined in serum from venous blood samples.
Muscle strengthWeek 0 (baseline), 2, 5, 9 (during intervention) and 12 (after training intervention)Time course changes in maximum isoinertial strength defined by one-repetition maximum in leg press, knee extension, knee flexion, and bench press.
Muscle fiber cross-sectional areaWeek 0 (baseline), 2 and 12 (post training intervention)Changes in muscle fiber cross-sectional area assessed by immunohistochemistry from muscle biopsy. Determined from muscle biopsy samples (Vastus lateralis).
Protein expressionWeek 0 (baseline), 2 and 12 (post training intervention)Changes in relative abundance of contractile protein isoforms (myosin heavy chain). Modification of proteins related to muscle hypertrophy in relation to an acute exercise session (assessed during week 2 of the intervention). Determined from muscle biopsy samples (Vastus lateralis).
Gene expressionWeek 0 (baseline), 2 and 12 (post training intervention)Changes in gene expression related to skeletal muscle hypertrophy and structural phenotype measured in steady state conditions (biopsy sampled in resting conditions, week 0, 2 and 12) and in relation to acute exercise (biopsy sampled 1-h after strength exercise, week 2). Determined from muscle biopsy samples (Vastus lateralis).

Other

MeasureTime frameDescription
Body composition changesWeek 0 (baseline) and 12 (post training intervention)Changes in body compositions (lean mass and fat mass) from prior intervention to after intervention assessed by dual x-ray absorptiometry scan.
Habitual physical activityWeek 0Self-reported prior habitual physical activity assessed by questionnaire and interview before training intervention
Daily nutrient intakeWeek 6Daily nutrient intake assessed by a 4-day food intake registration.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026